Cibc Private Wealth Group, LLC Acelrx Pharmaceuticals Inc Transaction History

Cibc Private Wealth Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$2.13 - $4.8 $21,406 - $48,240	-10,050 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.6 - $4.6 $26,000 - $46,000	10,000 Added 20000.0%	10,050 $39,000
Q4 2017 Feb 12, 2018	BUY	$1.75 - $5.5 $87 - $275	50	50 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.